Literature DB >> 9153526

Cerebral generators involved in the pathogenesis of the restless legs syndrome.

S F Bucher1, K C Seelos, W H Oertel, M Reiser, C Trenkwalder.   

Abstract

The pathophysiology of periodic limb movements and sensory leg discomfort in the restless legs syndrome is unknown. With high-resolution functional magnetic resonance imaging, we localized for the first time cerebral generators associated with sensory leg discomfort and periodic limb movements in 19 patients with restless legs syndrome. During sensory leg discomfort there was mainly bilateral activation of the cerebellum and contralateral activation of the thalamus. During the combined periodic limb movement and sensory leg discomfort conditions, patients also showed activity in the cerebellum and thalamus. In contrast to the sensory leg discomfort condition alone, the combined condition was associated with additional activation in the red nuclei and brainstem close to the reticular formation. Voluntary imitation of periodic limb movements by patients and control subjects was not associated with brainstem activity, but with additional activation in the globus pallidus and motor cortex. These findings indicate that cerebellar and thalamic activation may occur because of sensory leg discomfort and that the red nucleus and brainstem are involved in the generation of periodic limb movements in patients with restless legs syndrome.

Entities:  

Mesh:

Year:  1997        PMID: 9153526     DOI: 10.1002/ana.410410513

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  46 in total

Review 1.  Functional magnetic resonance imaging: clinical applications and potential.

Authors:  P M Matthews; S Clare; J Adcock
Journal:  J Inherit Metab Dis       Date:  1999-06       Impact factor: 4.982

2.  Restless Legs Syndrome.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-09       Impact factor: 3.598

Review 3.  Role of dopamine receptor agonists in the treatment of restless legs syndrome.

Authors:  Svenja Happe; Claudia Trenkwalder
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

4.  Investigation of unmedicated early onset restless legs syndrome by voxel-based morphometry, T2 relaxometry, and functional MR imaging during the night-time hours.

Authors:  P N Margariti; L G Astrakas; S G Tsouli; G M Hadjigeorgiou; S Konitsiotis; M I Argyropoulou
Journal:  AJNR Am J Neuroradiol       Date:  2011-12-15       Impact factor: 3.825

Review 5.  Restless legs syndrome: pathophysiology, clinical presentation and management.

Authors:  Claudia Trenkwalder; Walter Paulus
Journal:  Nat Rev Neurol       Date:  2010-06       Impact factor: 42.937

6.  The significance of the sympathetic nervous system in the pathophysiology of periodic leg movements in sleep.

Authors:  Adrian G Guggisberg; Christian W Hess; Johannes Mathis
Journal:  Sleep       Date:  2007-06       Impact factor: 5.849

7.  History of the development of sleep medicine in the United States.

Authors:  John W Shepard; Daniel J Buysse; Andrew L Chesson; William C Dement; Rochelle Goldberg; Christian Guilleminault; Cameron D Harris; Conrad Iber; Emmanuel Mignot; Merrill M Mitler; Kent E Moore; Barbara A Phillips; Stuart F Quan; Richard S Rosenberg; Thomas Roth; Helmut S Schmidt; Michael H Silber; James K Walsh; David P White
Journal:  J Clin Sleep Med       Date:  2005-01-15       Impact factor: 4.062

8.  Lack of specific gray matter alterations in restless legs syndrome in elderly subjects.

Authors:  Sébastien Celle; Frédéric Roche; Roland Peyron; Isabelle Faillenot; Bernard Laurent; Vincent Pichot; Jean-Claude Barthélémy; Emilia Sforza
Journal:  J Neurol       Date:  2009-09-22       Impact factor: 4.849

Review 9.  [Neurophysiological and neuroimaging studies for restless legs syndrome and periodic leg movement disorder].

Authors:  S Happe; W Paulus
Journal:  Nervenarzt       Date:  2006-06       Impact factor: 1.214

Review 10.  Deep brain stimulation: current and future clinical applications.

Authors:  Mark K Lyons
Journal:  Mayo Clin Proc       Date:  2011-06-06       Impact factor: 7.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.